Simultaneous diagnosis of allergic bronchopulmonary aspergillosis and Mycobacterium avium complex lung disease.
Naoki TakasakaKentaro ChidaTakeo IshikawaKazuyoshi KuwanoPublished in: BMJ case reports (2023)
Allergic bronchopulmonary aspergillosis (ABPA) and Mycobacterium avium complex lung disease (MAC-LD) often coexist because bronchiectasis, caused by ABPA or MAC, might be an important predisposing factor for both conditions. Here, we describe a man with asthma symptoms who had centrilobular small nodules and mucoid impaction on chest CT. We diagnosed the patient with simultaneous ABPA and MAC-LD on the basis of bronchoscopy findings. Itraconazole monotherapy led to substantial clinical improvement, avoiding the adverse effects of systemic corticosteroids. Sputum culture conversion of MAC was achieved after switching from itraconazole monotherapy to combination therapy comprising clarithromycin, rifampicin and ethambutol. ABPA recurred but was controlled by reinitiation of itraconazole. Overall, corticosteroid management was avoided for 38 months. Itraconazole monotherapy may be selected as initial treatment for ABPA with chronic infection, including MAC.
Keyphrases
- combination therapy
- mycobacterium tuberculosis
- cystic fibrosis
- allergic rhinitis
- pulmonary tuberculosis
- helicobacter pylori
- computed tomography
- emergency department
- case report
- open label
- magnetic resonance imaging
- lung function
- magnetic resonance
- sleep quality
- image quality
- depressive symptoms
- positron emission tomography
- study protocol